ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "autoantibodies"

  • Abstract Number: 1708 • 2014 ACR/ARHP Annual Meeting

    The Pathogenic Role of Immune Complexes Containing Scleroderma-Specific Autoantibodies in the Inductor Phase of the Disease

    Cecilia B. Chighizola1, Elena Raschi2, Laura Cesana2, Silvana Zeni3, Maria Orietta Borghi4 and Pier Luigi Meroni5,6, 1Rheumatology, Istituto Auxologico Italiano, University of Milan, Cusano Milanino, Italy, 2Istituto Auxologico Italiano, Milan, Italy, 3Division of Rheumatology, Istituto G. Pini, Milano, Italy, 4Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, 5Department of Clinical Sciences and Community Health, Division of Rheumatology, Istituto G. Pini, Milan, Italy, 6Chair and Division of Rheumatology, Gaetano Pini Institute, University of Milan, Milan, Italy

    Background/Purpose: Systemic sclerosis (SSc) is a chronic autoimmune condition characterized by excessive tissue fibrosis, microvascular alterations and immune dysfunction with the production of peculiar autoantibodies.…
  • Abstract Number: 982 • 2014 ACR/ARHP Annual Meeting

    Identification of Potential SERUM Autoantibody Biomarkers in Rheumatic Diseases Using a New Generation of Protein Arrays

    Lucia Lourido1, Juan Fernandez-Tajes1, Valentina Calamia1, Carolina Fernandez-Costa1,2, Beatriz Rocha1, Patricia Fernandez-Puente1, Jesus Mateos1, Carlos Fernandez-Lopez1, Natividad Oreiro-Villar1, Manuel Fuentes3, Francisco J. Blanco Garcia1 and Cristina Ruiz-Romero1, 1Grupo de Proteomica-PBR2-ProteoRed/ISCIII-Servicio de Reumatologia. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006., A Coruña, Spain, 2Grupo de Proteomica-PBR2-ProteoRed/ISCIII-Servicio de Reumatologia. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006., A coruña, Spain, 3Centro de Investigación del Cáncer/IBMCC (USAL/CIC), IBSAL, Departamento de Medicina, Unidad de Proteomica Servicio general de Citometría, Universidad de Salamanca, Salamanca, SPAIN., Salamanca, Spain

    Background/Purpose Osteoarthritis (OA) is characterized by the loss of structural components from the extracelullar matrix (ECM) of articular cartilage. The progressive release of proteins from…
  • Abstract Number: 2991 • 2014 ACR/ARHP Annual Meeting

    Anti-Ribosomal P Antibody Is a Key Autoantibody Associated with Complications of NP-SLE with High-Levels of CSF IL-8

    Hidenaga Kawasumi1, Takahisa Gono1, Yasushi Kawaguchi1, Yasuhiro Katsumata1, Hisae Ichida1, Akiko Tochimoto1, Masanori Hanaoka1, Yuko Okamoto1, Sayuri Kataoka1 and Hisashi Yamanaka2, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

    Background/Purpose: Complications of neuropsychiatric systemic lupus erythematosus (NP-SLE) are associated with the morbidity and mortality of patients with SLE. Although the detailed pathophysiology of NP-SLE…
  • Abstract Number: 1692 • 2014 ACR/ARHP Annual Meeting

    The Additive Value of Nailfold Videocapillaroscopy Patterns to Disease-Specific Autoantibodies in Discrimination of Patients with Systemic Sclerosis at Risk for Severe Organ Involvement

    I.M. Markusse1, J. Meijs2, B. de Boer2, A. a. Schouffoer1, N. Ajmone Marsan3, L. J. M. Kroft4, M. K. Ninaber5, T. W. J. Huizinga2 and J.K. de Vries-Bouwstra6, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Cardiology, Leiden University Medical Center, Leiden, Netherlands, 4Deparment of Radiology, Leiden University Medical Center, Leiden, Netherlands, 5Pulmonology, Leiden University Medical Center, Leiden, Netherlands, 6Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Severe nailfold videocapillaroscopy (NVC) patterns in patients with systemic sclerosis (SSc) are associated with a high risk of organ involvement. SSc-specific autoantibodies seem to…
  • Abstract Number: 914 • 2014 ACR/ARHP Annual Meeting

    A Predictive Model of Disease Outcome in Rituximab-Treated Myositis Patients Using Clinical Features, Autoantibodies, and Serum Biomarkers

    Jeannette Olazagasti1, Cynthia S. Crowson2, Molly S. Hein1, Consuelo Lopez de Padilla1, Rohit Aggarwal3, Chester V. Oddis4 and Ann M. Reed1, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Health Sciences Research, Mayo Clinic, Rochester, MN, 3Medicine, University of Pittsburgh, Pittsburgh, PA, 4Rheum/Clinical Immunology, University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Develop predictive models of early (8 week) and late (24 week) disease outcomes using clinical features, autoantibodies, and serum biomarkers in patients with refractory…
  • Abstract Number: 2908 • 2014 ACR/ARHP Annual Meeting

    Flip Deficiency in Dendritic Cells Promotes Spontaneous Arthritis Mediated By Reduced Treg and Increased Autoreactive CD4+t Cells

    Qiquan Huang1, Harris R. Perlman2, Robert Birkett3, Renee E. Doyle4, Deyu Fang5, G Kenneth.Haines6, William H. Robinson7, Syamal K. Datta8, Hyewon Phee9 and Richard M. Pope10, 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Northwestern University Feinberg School of Medicine, Chicago, IL, 3Division of Rheumatology, Department od Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 5Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, 6Mount Sinai Hospital School of Medicine, New York, New York, NY, 7VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 8Rheumatology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, 9Department of Microbiology-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL, 10Rheumatology, Northwestern University Feinberg school of Medicine, Chicago, IL

    Background/Purpose Flip (CFLAR) has been identified as a rheumatoid arthritis (RA) risk allele and is important in preventing death receptor mediated apoptosis of dendritic cells…
  • Abstract Number: 1645 • 2014 ACR/ARHP Annual Meeting

    Interferon Gene Signature Expression and Serological Differences in Japanese and Non-Japanese SLE Patients

    Hitoshi Kohsaka1, Kosuke Kotani2, Tomonori Ishii3, Tomoya Miyamura4, Masato Okada5, Toshihiko Aranishi2, R. Maciuca6, William P. Kennedy6 and Junko Ohata2, 1Department of Rheumatology, Graduate School of Medical and Dental Sciences,, Tokyo Medical and Dental University (TMDU), Tokyo, Japan, 2Chugai Pharmaceutical co., ltd, Tokyo, Japan, 3Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, 4Department of Internal Medicine and Rheumatology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan, 5Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 6Genentech, Inc, South San Francisco, CA

    Background/Purpose: Elevated expression of interferon(IFN)-regulated genes in peripheral blood cells has been reported in systemic lupus erythematosus (SLE) patients and is known as the IFN…
  • Abstract Number: 887 • 2014 ACR/ARHP Annual Meeting

    Serological and Clinical Characteristics of a Large Collection of Incomplete Lupus Erythematosus Patients

    Teresa Aberle1, Virginia C. Roberts1, Julie M. Robertson1, Joel M. Guthridge1, Kathy L. Sivils2, Astrid Rasmussen2, David R. Karp3 and Judith James4, 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 2Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX, 4Arthritis & Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Incomplete lupus (ILE) is defined as a condition in which patients present with signs of systemic autoimmunity and clinical manifestations compatible with systemic lupus…
  • Abstract Number: 2891 • 2014 ACR/ARHP Annual Meeting

    Inflammatory Genes Are Associated with Autoantibodies in Rheumatoid Arthritis-Free Individuals Who Are at-Risk for Future Disease

    Ryan W. Gan1, Kendra A. Young1, M. Kristen Demoruelle2, Michael H. Weisman3, Jane H. Buckner4, P. K. Gregersen5, Ted R. Mikuls6, James R. O'Dell6, Richard M. Keating7, Elizabeth W. Karlson8, Kevin D. Deane2, V. Michael Holers9 and Jill M. Norris1, 1Epidemiology, Colorado School of Public Health, Aurora, CO, 2Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 3Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 4Benaroya Research Institute at Virginia Mason, Seattle, WA, 5Genomics and Human Genetics, Feinstein Institute Medical Research and North Shore-Long Island Jewish Health System, Manhasset, NY, 6Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 7Division of Rheumatology, Scripps Clinic, La Jolla, CA, 8Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 9Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: We previously found that presence of rheumatoid arthritis(RA)-related autoantibodies is associated with systemic inflammation, and that decreased consumption of anti-inflammatory omega-3 fatty acids (n-3…
  • Abstract Number: 1644 • 2014 ACR/ARHP Annual Meeting

    Mycophenolic Acid and Ribavirin Induces Cytoplasmic Autoimmunogenic Rods and Rings Structures in Vivo

    Gerson D Keppeke Sr.1, Eunice Nunes2, Maria Lucia Ferraz3, Sandro F. Perazzio1, Mônica Prado1, Edward K.L. Chan4 and Luis Eduardo C. Andrade5, 1Rheumatology, Escola Paulista de Medicina - Universidade Federal de São Paulo, Sao Paulo, Brazil, 2Gastroenterology Division, Universidade Federal de São Paulo, Sao Paulo, Brazil, 3Gastroenterology Division, Universidade Federal de São Paulo, São Paulo, Brazil, 4Oral Biology, University of Florida, Gainesville, FL, 5Fleury Laboratories, Sao Paulo, Brazil

    Background/Purpose Autoantibodies to IMPDH2 occur in Hepatitis C patients receiving ribavirin (RBV) & interferon-α (IFN-α). Anti-IMPDH2 antibodies recognize “rods and rings” (RR) cytoplasmic structures in…
  • Abstract Number: 861 • 2014 ACR/ARHP Annual Meeting

    Ultraviolet B Generates Type 1 Interferon and Induces Autoantibody-Mediated Disease in a Mouse Model of Cutaneous Lupus

    Clayton Sontheimer1 and Keith B. Elkon2, 1Pediatric Rheumatology, University of Washington, Seattle, WA, 2Division of Rheumatology, University of Washington, Seattle, WA

    Background/Purpose Photosensitivity is a common symptom in patients with systemic lupus erythematosus (SLE) and lupus skin lesions often contain plasmacytoid dendritic cells (pDC). The mechanisms…
  • Abstract Number: 2872 • 2014 ACR/ARHP Annual Meeting

    B-Cell Autoepitope and Tetramer Analysis Reveals Expansion of Apoptotic Autoantigen La and snRNP Reactive B Cells in BXD2 Mice

    Jennie Hamilton1, Jun Li2, Qi Wu3, PingAr Yang3, Bao Luo3, Hao Li4, Troy Randall5, John Edwin Bradley5, Justin J. Taylor6, John D. Mountz7,8 and Hui-Chen Hsu3,4, 1University of Alabama at Birmingham, Birmingham, AL, 2Med - Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 3Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 4Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 6Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 7Dept of Med/Rheumatology Div, University of Alabama at Birmingham, Birmingham, AL, 8Birmingham VA Medical Center, Birmingham, AL

    Background/Purpose Systemic lupus erythematous (SLE) is characterized by production of highly pathogenic IgG autoantibodies (autoAbs).  While serum autoAb profiling is standard, it remains challenging to…
  • Abstract Number: 1606 • 2014 ACR/ARHP Annual Meeting

    Profiling a Broad Range of Autoantibodies in Healthy and Systemic Lupus Erythematosis   Revealed Autoantibody Patterns Associated with Autoantibody Transition and Disease Activity

    Quan-Zhen Li Li1, Edward Wakeland2, Prithvi Raj3, Honglin Zhu2, Xiaoxia Zuo4, Mei Yan5 and Indu Raman6, 1Immunology and internal medicine, University of Texas Southwestern Medical Center, Dallas, TX, 2Immunology, University of Texas Southwestern Medical Center, Dallas, TX, 3Immunology, University of Texas Southwestern Medical Center, dallas, TX, 4Rheumatology, Xiangya Hospital of Hunan Medical Univ, Changsha, China, 5Internal Medicine/Division of Rheumatology, University of Texas Southwestern Medical Center, Dallas, TX, 6Department of Immunology and Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX

    Background/Purpose: Autoantibodies targeting to nuclear antigens are serological hallmarks of SLE, however, the processing of autoantibody production during the transition from normal to autoimmunity and…
  • Abstract Number: 780 • 2014 ACR/ARHP Annual Meeting

    Novel Roles for Zyxin in the Pathogenesis of Giant Cell Arteritis

    Rie Karasawa1, Paul A. Monach2, Mayumi Tamaki1, Takahiro Okazaki3, Masamichi Oh-Ishi4, Yoshio Kodera4, Toshiko Sato1, Shoichi Ozaki5, Kaiyu Jiang6, Kazuo Yudoh1, James N. Jarvis7 and Peter A. Merkel8, 1Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan, 2Section of Rheumatology, Vasculitis Center, Boston University School of Medicine, Boston, MA, 3Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 4School of Science, Kitasato University, Sagamihara, Japan, 5Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 6415 Carmen Road, Apt. 1, The University at Buffalo, Buffalo, NY, 7Pediatrics, The University at Buffalo, Buffalo, NY, 8Vasculitis Center, Division of Rheumatology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose �:The mechanisms of the blood vessel injury in giant cell arteritis (GCA), a systemic vasculitis characterized by inflammation of large- and medium-sized vessels, remain…
  • Abstract Number: 2874 • 2014 ACR/ARHP Annual Meeting

    Pro-Inflammatory FcRL4+ Memory B Cells in Joints of RA Patients: Immunoglobulin Gene Characteristics and Antigen Specificity

    Khaled Amara1, Lorraine Yeo2, Natalie Sippl1, Philip Titcombe1, Andrew Filer3, Karim Raza3, Dagmar Scheel-Toellner2 and Vivianne Malmström4, 1Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Karolinska Institutet, SE-17176 Solna, Stockholm, Sweden., Stockholm, Sweden, 2Rheumatology Research Group, Centre for Translational Inflammation Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham B15 2TT, UK, Birmingham, United Kingdom, 3Rheumatology Research Group, MRC Centre for Immune Regulation, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom, 4Medicine, Rheumatology Unit, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose:    Our recent findings identified a subset of pro-inflammatory memory B cells in the RA synovium characterized by the expression of the surface protein…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 28
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology